In Vitro Diagnostic Industry in China

This book systematically describes the achievements and current situation of in vitro diagnostic (IVD) industry in China. It consists of twelve parts, including the overview on the IVD industry in China in 2021, hot technologies and products of IVD industry, academic, technological and product development in the field of IVD, such as biochemical diagnosis, immune-diagnosis, point-of-care testing, molecular diagnosis, blood and body fluid diagnosis, microbial detection, laboratory assembly line, etc. In this second edition, the new contents added include the development of new coronavirus molecular diagnostic products, flight mass spectrometry, tandem mass spectrometry, tumor markers, ELISA immune reagents, autoimmune diagnostics, concomitant diagnosis, fecal and intestinal microecology detection, pathological diagnosis, raw materials for in vitro diagnostic reagents, standard substances and quality controls for in vitro diagnostic reagents, etc., making the content of the whole book more novel and rich. This book is compiled by an editorial committee composed of well-known entrepreneurs, experts and professors in IVD industry in China. It is a reference book for practitioners of IVD industry, medical laboratory and medical staffs all over the world.

Including current situation and trend of research and technology development Covering the products related IVD industry in China Providing valuable reference for workers of IVD industry, medical laboratory and various medical staffs

Auteur
Professor Haibo Song successively served as Deputy Director of Anhui Provincial Center for Clinical Laboratories, Senior technician. He is now Vice Chairman of National Association of Health Industry and Enterprises Management, Chairman of China Association of In Vitro Diagnostics, Vice chairman of Labelling Immunoassay Professional Committee of China Association for Instrumental Analysis, Vice Chairman and Secretary General of Professional Committee of Experimental Medicine, Standing committee member of the National Medical Clinical Laboratory and the Standardization Technical Committee of the In Vitro Diagnostic System, Associate Dean of Shanghai Academy of Experimental Medicine, Founder of CACLP.

Dr. Dia Lizhong, graduated from Peking University, Ph.D. from Princeton University, postdoctoral fellow of MIT, National Science Advisor, expert of special government allowance of the State Council, and leader of the in vitro diagnostics in China. Executive Director of the China Medical Equipment Association, Vice President of Medical Laboratory Industry Branch of National Health Industry Enterprise Management Association, Vice Chairman of Hunan Federation of Industry and Commerce, Vice President of Hunan Preventive Medicine Association, Vice President of Hunan Pharmaceutical Industry Association, Vice President of Hunan Medical Device Association. Chairman of Shengxiang Biotechnology Co., Ltd.

Contenu

Current Status and Progress.- Opportunities and Challenges.- Chemiluminescence Instruments and Reagents.- Fully automated enzyme immunological instruments and related instruments.- Autoimmune Diagnostics.- Tumor Markers.- ELISA Immunological Reagents.- Biochemical Analytical Instruments and Reagents.- Electrolyte Analysis Techniques.- Blood Gas Analysis Techniques.- Biochemical Assembly Lines.- Molecular Diagnosis of Novel Coronavirus.- Molecular Diagnostic Analyzers and Reagents.- Overview.- Domestic and Foreign Real-time Detection Market Situation.- Major Domestic Manufacturers.- Hemagglutination instruments and reagents.- Blood Group Detection Instruments and Supporting Reagents.- Urine.- Stool and Intestinal Microecology Testing.- Semen.- Vaginal Discharge.- Blood Cell Analyzers and Reagents.- Microbial Culture Analyzers and Reagents.- Concomitant Diagnosis.- Flight Mass Spectrometry Techniques.- Tandem Mass Spectrometry.- Overview of Pathological Diagnosis.- Routine Pathology.-Cytopathology.- Immunohistochemistry.- Molecular Pathology.- Numeral Pathology.- Classification and Status of Raw Materials for In Vitro Diagnostics.- Bottlenecks and Favorable Factors for the Development of Raw Materials for In Vitro Diagnostic Reagents.- Development and Application status of National Reference Materials for In Vitro Diagnostic Reagents.- Research and Development, Production, and Application status of quality controls for in vitro diagnostic reagents.- 2021 Results of Listed Companies.- Investment and Financing Mergers and Acquisitions of Listed Companies in 2021.